Asia Deal Watch: Fujifilm Affiliate Out-Licenses Antifungal Candidate To Canada’s Appili

28 Nov 2019

• By Ian Haydock, Joseph Haas, Vibha Ravi, and Jung Won Shin

Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.

FUJIFILM has licensed ex-Japanese rights to a novel antifungal to Appili

Asia Deal Watch: Fujifilm Affiliate Out-Licenses Antifungal Candidate To Canada’s Appili

More from Focus On Asia

More from Scrip